Glenmark Pharma Announces Launch of Potassium Phosphates Injection in the U.S
Glenmark Pharmaceuticals Ltd has announced that its U.S. subsidiary, Glenmark Pharmaceuticals Inc., will soon launch Potassium Phosphates Injection USP in the United States market. The product will be available in different vial sizes including 5 mL, 15 mL single-dose vials and a 50 mL pharmacy bulk package vial. The company said the injection is bioequivalent … Read more